An FDA perspective on the assessment of proposed biosimilar therapeutic proteins in rheumatology
Crossref DOI link: https://doi.org/10.1038/nrrheum.2016.204
Published Online: 2017-01-05
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nikolov, Nikolay P.
Shapiro, Marjorie A.
Text and Data Mining valid from 2017-01-05
Article History
First Online: 5 January 2017
Competing interests
: The authors declare no competing financial interests.